Background The systemic inflammation response index (SIRI), a novel and cost-effective
serum biomarker, is associated with prognosis in patients with cancer. However, the …

Gastric cancer is the fifth most frequently diagnosed cancer worldwide, behind breast, lung,
colorectal, and prostate cancers. In gastric cancer, multimodality treatment shows …

Abstract Background The Coronavirus 2019 is a pandemic that has spread worldwide,
threatening human health. The main cause of death in patients with COVID-19 is a systemic …

Background Inflammation is closely associated with the initiation and development of
tumors. Based on the counts of peripheral neutrophils, monocytes and lymphocytes, we …

Background: This meta-analysis aimed to evaluate the prognostic value of the systemic
inflammation response index (SIRI) in malignancy based on existing evidence. Methods: We …

Inflammation indicators, such as systemic inflammation response index (SIRI), systemic
immune‐inflammation index (SII), neutrophil‐to‐lymphocyte ratio (NLR) and platelet …

Background Inflammation plays an essential role in the pathogenesis of hypertension. A
novel inflammatory biomarker systemic inflammatory response index (SIRI) is related with all …

Background. The systemic immune‐inflammation index (SII), based on peripheral
lymphocytes, neutrophils, and platelet count, has been used as a prognostic marker for …

Background Pre-treatment PLR (platelet-lymphocyte ratio) was reported to be associated
with the prognosis in gastric cancer (GC), but the results remain inconclusive. This meta …

Background and Objective Systemic inflammation response index (SIRI= N× M/L), based on
neutrophil (N), monocyte (M), and lymphocyte (L) counts, is used to predict the survival of …